A Preliminary Report on the Role of Liv.52 – An Indigenous Drug in Serum B Hepatitis Cases

Patney, N.L., M.D., M.A.M.S. (Med.), M.R.C.P. (Lond.), M.R.C.P. (Glas.), D.T.M.& H. (Edin.), D.T.C.D. (Wales) and Ashok Kumar, M.Sc. Postgraduate Department of Medicine, S.N. Medical College, Agra, India.

Two groups of patients, one consisting of 6 patients and the second of 14 patients were treated on regimen I i.e. oral glucose, vitamins B and C and steroid-Prednisolone 5 mg t.i.d. and regimen II, i.e. oral glucose, vitamins B and C, steroid along wit